The value of HPV genotypes: not all high risk HPV genotypes are at equal risk
Tuesday, December 4, 2018
Clinical Session
•
CS 06
•
1:30 PM
>
3:00 PM
•
The value of HPV genotypes: not all high risk HPV genotypes are at equal risk
•
Aud. III / IV
Oncogenic HPV genotypes have different risk of disease. Transforming this knowledge into screening relevant assays and clinical screening algorithms is ongoing. The session aims at providing the audience with the current state of the art and perspectives for use of HPV genotype information to predict risks, guide management, use in triage strategies and HPV genotyping for screening of vaccinated women.
1:30 PM
•
CS 06-01
•
Introduction
>
J.
Jesper
BONDE
1:35 PM
•
CS 06-02
•
Different types, different risks and triage strategies
>
N.
Nicolas
WENTZENSEN
1:53 PM
•
CS 06-03
•
HPV genotype results to predict risk and guide management in cervical cancer secondary prevention from a systematic review
>
J.
Jeffrey
ANDREWS
2:11 PM
•
CS 06-04
•
Combining clinical screening assay requirements with genotyping Valgent4
>
J.
Jesper
BONDE
2:29 PM
•
CS 06-05
•
Validation of HPV genotyping assays
>
M.
Marc
ARBYN
2:47 PM
•
CS 06-06
•
Discussion and questions
|